SwissMedic-2021-0049-V049
Major variation for application SwissMedic-2021-0049. Major variation: Formulation Change for Brextanib — major revision
Variation Number
SwissMedic-2021-0049-V049
Type
Major
Application
Change
Status
Failed
Fee
€34,086
Submitted
2023-03-17
Approved
—
Description
Major variation: Formulation Change for Brextanib — major revision